Valuation: China Isotope & Radiation Corporation

Market Cap 465.93Cr 542.19Cr 69Cr 60Cr 56Cr 51Cr 96Cr 6.59TCr 98Cr 659.65Cr 257.85Cr 3.3TCr 259.41Cr 253.77Cr 11TCr P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 477.81Cr 556.02Cr 71Cr 61Cr 58Cr 52Cr 99Cr 6.76TCr 100.14Cr 676.47Cr 264.43Cr 3.38TCr 266.02Cr 260.24Cr 11TCr EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.21%
Yield 2024
3.74%
Yield 2025 1.69%
06/07 China Isotope to Form JV With Associate MT
03/07 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
18/06 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
18/06 China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board CI
27/05 China Isotope Proposes Auditor Change MT
26/05 China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026 CI
27/03 China Isotope & Radiation final cash dividend of RMB0.2264 per share RE
27/03 China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026 CI
27/03 China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
19/03 China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection RE
14/03 China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement CI
13/03 China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality RE
02/03 China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer MT
1 week+0.18%
Current month+4.31%
1 month+2.73%
3 months-10.74%
6 months-17.72%
Current year-16.09%
1 week 16.7
Extreme 16.7
17.82
1 month 16.09
Extreme 16.09
17.99
Current year 16.09
Extreme 16.09
24.28
1 year 15.2
Extreme 15.2
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
29.85
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 55 02/08/2024
Corporate Secretary - 30/08/2024
Corporate Secretary - 30/08/2024
Director TitleAgeSince
Director/Board Member 57 22/02/2017
Director/Board Member 54 28/06/2019
Director/Board Member 54 30/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.18%-5.57%+24.08% 69Cr
+0.01%+1.18%+199.66%+363.92% 2.22TCr
-0.89%-0.14%-42.63%-22.93% 992.31Cr
-1.25%+21.68%+350.82%+14.18% 752.43Cr
+0.05%-0.76%+86.88%+45.99% 657.49Cr
-3.80%+35.32%-31.42% - 629.06Cr
-0.62%+3.14%-16.36%-12.93% 559.37Cr
+1.30%+2.91%+79.08%+100.78% 446.05Cr
+0.30%-0.27%-10.79%-18.65% 423.01Cr
-0.92%-1.04%-23.56%-35.76% 273.86Cr
Average -0.58%+6.04%+58.61%+50.97% 701.84Cr
Weighted average by Cap. -0.58%+6.19%+102.04%+132.44%

Financials

2024 2025
Net sales 757.48Cr 881.45Cr 112.32Cr 97Cr 91Cr 83Cr 156.36Cr 11TCr 158.76Cr 1.07TCr 419.2Cr 5.36TCr 421.73Cr 412.56Cr 18TCr 718.77Cr 836.41Cr 106.58Cr 92Cr 87Cr 79Cr 148.37Cr 10TCr 150.64Cr 1.02TCr 397.78Cr 5.09TCr 400.18Cr 391.48Cr 17TCr
Net income 41Cr 47Cr 6.03Cr 5.22Cr 4.89Cr 4.46Cr 8.39Cr 575.13Cr 8.52Cr 58Cr 23Cr 287.98Cr 23Cr 22Cr 960.25Cr 33Cr 38Cr 4.86Cr 4.21Cr 3.94Cr 3.59Cr 6.76Cr 463.09Cr 6.86Cr 46Cr 18Cr 231.88Cr 18Cr 18Cr 773.18Cr
Net Debt -11Cr -13Cr -1.62Cr -1.4Cr -1.31Cr -1.2Cr -2.25Cr -154.07Cr -2.28Cr -15Cr -6.03Cr -77Cr -6.06Cr -5.93Cr -257.23Cr 12Cr 14Cr 1.76Cr 1.53Cr 1.43Cr 1.3Cr 2.45Cr 168.08Cr 2.49Cr 17Cr 6.58Cr 84Cr 6.62Cr 6.47Cr 280.63Cr
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,578
Date Price Change Volume
13/26/13 HK$16.95 0.00% 54,400
12/26/12 HK$16.95 -1.51% 22,000
11/26/11 HK$17.21 +1.71% 32,400
10/26/10 HK$16.92 +0.53% 75,200
07/26/07 HK$16.83 -0.53% 7,600

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1763 Stock